본문 바로가기
KERD
논문KCI 등재

Overview of Helicobacter pylori Infection in Indonesia: What Distinguishes It from Countries with High Gastric Cancer Incidence?

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Helicobacter pylori infects more than half the human population. However, the prevalence in Indonesia is low, as is the prevalence of gastric cancer. Hence, it could be instructive to compare these prevalence rates and their determining factors with those of countries that have high gastric cancer incidence. Ethnicity and genetic characteristics of H. pylori are important determinants of the H. pylori infection rate in Indonesia. The infection rate is higher in Bataknese, Papuans and Buginese than in Javanese, the predominant ethnic group. Ethnicity is also an important determinant of the genetic characteristics of H. pylori. Analysis of CagA in the EPIYA segment showed that the predominant genotypes in Papuans, Bataknese and Buginese are ABB-, ABDand ABC-type CagA, respectively. Meanwhile, in the countries with high gastric cancer incidence, almost all strains had East Asian type CagA. An antibiotic susceptibility evaluation showed that the standard triple therapy can still be used with caution in several cities. There is a very high rate of resistance to second-line regimens such as levofloxacin and metronidazole. Recent studies have shown that furazolidone, rifabutin and sitafloxacin are potential alternative treatments for antibiotic-resistant H. pylori infection in Indonesia. Rather than focusing on early detection and eradication as in countries with high gastric cancer prevalence, countries with low gastric cancer prevalence should focus on screening the several groups that have a high risk of gastric cancer.

Abstract

Helicobacter pylori infects more than half the human population. However, the prevalence in Indonesia is low, as is the prevalence of gastric cancer. Hence, it could be instructive to compare these prevalence rates and their determining factors with those of countries that have high gastric cancer incidence. Ethnicity and genetic characteristics of H. pylori are important determinants of the H. pylori infection rate in Indonesia. The infection rate is higher in Bataknese, Papuans and Buginese than in Javanese, the predominant ethnic group. Ethnicity is also an important determinant of the genetic characteristics of H. pylori. Analysis of CagA in the EPIYA segment showed that the predominant genotypes in Papuans, Bataknese and Buginese are ABB-, ABDand ABC-type CagA, respectively. Meanwhile, in the countries with high gastric cancer incidence, almost all strains had East Asian type CagA. An antibiotic susceptibility evaluation showed that the standard triple therapy can still be used with caution in several cities. There is a very high rate of resistance to second-line regimens such as levofloxacin and metronidazole. Recent studies have shown that furazolidone, rifabutin and sitafloxacin are potential alternative treatments for antibiotic-resistant H. pylori infection in Indonesia. Rather than focusing on early detection and eradication as in countries with high gastric cancer prevalence, countries with low gastric cancer prevalence should focus on screening the several groups that have a high risk of gastric cancer.

참고문헌 (111)

  1. Kang SJ, "Helicobacter pylori eradication therapy for functional dyspepsia : a meta-analysis by region and H. pylori prevalence", J Clin Med, 8, pp.1324~ (2019)
  2. Suzuki H, "Helicobacter pylori infection in functional dyspepsia", Nat Rev Gastroenterol Hepatol, 10, pp.168~174 (2013)
  3. Zamani M, "Systematic review with meta-analysis : the worldwide prevalence of Helicobacter pylori infection", Aliment Pharmacol Ther, 47, pp.868~876 (2018)
  4. Hooi JKY, "Global prevalence of Helicobacter pylori infection : systematic review and metaanalysis", Gastroenterology, 153, pp.420~429 (2017)
  5. Ferlay J, "Global cancer observatory:cancer today" (2018), International Agency ror Research on Cancer
  6. "Global Cancer Observatory"[URL]
  7. Miftahussurur M, "Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia", PLoS One, 12, pp.e0176203~ (2017)
  8. Miftahussurur M, "Analysis of risks of gastric cancer by gastric mucosa among Indonesian ethnic groups", PLoS One, 14, pp.e0216670~ (2019)
  9. Gunaletchumy SP, "Helicobacter pylori genetic diversity and gastro-duodenal diseases in Malaysia", Sci Rep, 4, pp.7431~ (2014)
  10. Kang JY, "Racial differences in Helicobacter pylori seroprevalence in Singapore : correlation with differences in peptic ulcer frequency", J Gastroenterol Hepatol, 12, pp.655~659 (1997)
  11. Mahadeva S, "Epidemiology of functional dyspepsia : a global perspective", World J Gastroenterol, 12, pp.2661~2666 (2006)
  12. Miftahussurur M, "Diagnostic methods of Helicobacter pylori infection for epidemiological studies : critical importance of indirect test validation", Biomed Res Int, 2016, pp.4819423~ (2016)
  13. Syam AF, "Validation of urine test for detection of Helicobacter pylori infection in indonesian population", Biomed Res Int, 2015, pp.152823~ (2015)
  14. Makmun D, "Present status of endoscopy, therapeutic endoscopy and the endoscopy training system in Indonesia", Dig Endosc, 26(Suppl 2), pp.2~9 (2014)
  15. Kuipers EJ, "The prevalence of Helicobacter pylori in peptic ulcer disease", Aliment Pharmacol Ther, 9(Suppl 2), pp.59~69 (1995)
  16. Ford AC, "Global prevalence of, and risk factors for, uninvestigated dyspepsia : a meta-analysis", Gut, 64, pp.1049~1057 (2015)
  17. Syam AF, "Accuracy of Helicobacter pylori stool antigen for the detection of Helicobacter pylori infection in dyspeptic patients", World J Gastroenterol, 11, pp.386~388 (2005)
  18. Tokudome S, "Helicobacter pylori infection appears essential for stomach carcinogenesis : observations in Semarang, Indonesia", Cancer Sci, 96, pp.873~875 (2005)
  19. Tokudome S, "Rare Helicobacter pylori infection as a factor for the very low stomach cancer incidence in Yogyakarta, Indonesia", Cancer Lett, 219, pp.57~61 (2005)
  20. Abdullah M, "Helicobacter pylori infection and gastropathy : a comparison between Indonesian and Japanese patients", World J Gastroenterol, 15, pp.4928~4931 (2009)
  21. Zhao Y, "Association between HLADQ genotypes and haplotypes vs Helicobacter pylori infection in an Indonesian population", Asian Pac J Cancer Prev, 13, pp.1247~1251 (2012)
  22. Miftahussurur M, "Identification of Helicobacter pylori infection in symptomatic patients in Surabaya, Indonesia, using five diagnostic tests", Epidemiol Infect, 143, pp.986~996 (2015)
  23. Miftahussurur M, "Surveillance of Helicobacter pylori antibiotic susceptibility in Indonesia : different resistance types among regions and with novel genetic mutations", PLoS One, 11, pp.e0166199~ (2016)
  24. Miftahussurur M, "Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance", Infect Drug Resist, 12, pp.345~358 (2019)
  25. Sahara S, "Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries : a meta-analysis", BMC Infect Dis, 12, pp.223~ (2012)
  26. Destura RV, "Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines", Ann Clin Microbiol Antimicrob, 3, pp.25~ (2004)
  27. Syam AF, "Risk factors and prevalence of Helicobacter pylori in five largest islands of Indonesia : a preliminary study", PLoS One, 10, pp.e0140186~ (2015)
  28. Miftahussurur M, "Extremely low Helicobacter pylori prevalence in North Sulawesi, Indonesia and identification of a Maori-tribe type strain : a cross sectional study", Gut Pathog, 6, pp.42~ (2014)
  29. Quach DT, "Helicobacter pylori infection and related gastrointestinal diseases in southeast asian countries : an expert opinion survey", Asian Pac J Cancer Prev, 19, pp.3565~3569 (2018)
  30. Yamazaki S, "Distinct diversity of vacA, cagA, and cagE genes of Helicobacter pylori associated with peptic ulcer in Japan", J Clin Microbiol, 43, pp.3906~3916 (2005)
  31. Park IS, "Helicobacter pylori infection in Korea", Yonsei Med J, 42, pp.457~470 (2001)
  32. Ito Y, "Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan", J Clin Microbiol, 35, pp.1710~1714 (1997)
  33. Choi KD, "Analysis of the 3’ variable region of the cagA gene of Helicobacter pylori isolated in Koreans", Dig Dis Sci, 52, pp.960~966 (2007)
  34. Lee JH, "Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea : a prospective multicenter study", Helicobacter, 24, pp.e12592~ (2019)
  35. Lu H, "Duodenal ulcer promoting gene of Helicobacter pylori", Gastroenterology, 128, pp.833~848 (2005)
  36. Kageyama C, "Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan", Infect Drug Resist, 12, pp.597~602 (2019)
  37. Miyachi H, "Primary levofloxacin resistance and gyrA", B mutations among Helicobacter pylori in Japan, 2006, pp.11, 243~249
  38. Seo TH, "The origin of non-H. pylorirelated positive Giemsa staining in human gastric biopsy specimens : a prospective study", Dig Liver Dis, 43, pp.23~27 (2011)
  39. Ansari S, "Helicobacter pylori bab characterization in clinical isolates from Bhutan, Myanmar, Nepal and Bangladesh", PLoS One, 12, pp.e0187225~ (2017)
  40. Khan A, "Prevalence, diversity and disease association of Helicobacter pylori in dyspeptic patients from Pakistan", J Infect Dev Ctries, 7, pp.220~228 (2013)
  41. Aftab H, "Two populations of less-virulent Helicobacter pylori genotypes in Bangladesh", PLoS One, 12, pp.e0182947~ (2017)
  42. Goto Y, "Prevalence and risk factors for Helicobacter pylori infection among healthy inhabitants in Northern Jakarta, Indonesia", Asian Pac J Cancer Prev, 17, pp.4747~4753 (2016)
  43. Simadibrata M, "Dyspepsia and gastroesophageal reflux disease (GERD): is there any correlation?", Acta Med Indones, 41, pp.222~227 (2009)
  44. Hantoro IF, "Factors associated with health-related quality of life in patients with functional dyspepsia", Health Qual Life Outcomes, 16, pp.83~ (2018)
  45. Kandasami P, "Clinical and endoscopic features of peptic ulcer bleeding in Malaysia", Med J Malaysia, 59, pp.617~622 (2004)
  46. Kachintorn U, "Helicobacter pylori and peptic ulcer diseases : prevalence and association with antral gastritis in 210 patients", J Med Assoc Thai, 75, pp.386~392 (1992)
  47. Nguyen TL, "Helicobacter pylori infection and gastroduodenal diseases in Vietnam : a cross-sectional, hospital-based study", BMC Gastroenterol, 10, pp.114~ (2010)
  48. Binh TT, "Molecular epidemiology of Helicobacter pylori infection in a minor ethnic group of Vietnam : a multiethnic, population-based study", Int J Mol Sci, 19, pp.708~ (2018)
  49. Correa P, "Carcinogenesis of Helicobacter pylori", Gastroenterology, 133, pp.659~672 (2007)
  50. Yamaoka Y, "Mechanisms of disease : Helicobacter pylori virulence factors", Nat Rev Gastroenterol Hepatol, 7, pp.629~641 (2010)
  51. Uemura N, "Helicobacter pylori infection and the development of gastric cancer", N Engl J Med, 345, pp.784~789 (2001)
  52. Narayanan M, "Peptic ulcer disease and Helicobacter pylori infection", Mo Med, 115, pp.219~224 (2018)
  53. Bagheri N, "Up-regulated Th17 cell function is associated with increased peptic ulcer disease in Helicobacter pylori-infection", Infect Genet Evol, 60, pp.117~125 (2018)
  54. Takahashi A, "Intact long-type dupA as a marker for gastroduodenal diseases in Okinawan subpopulation, Japan", Helicobacter, 18, pp.66~72 (2013)
  55. Miftahussurur M, "Helicobacter pylori virulence genes in the five largest islands of Indonesia", Gut Pathog, 7, pp.26~ (2015)
  56. Chang WL, "The impacts of H. pylori virulence factors on the development of gastroduodenal diseases", J Biomed Sci, 25, pp.68~ (2018)
  57. Graham DY, "History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer", World J Gastroenterol, 20, pp.5191~5204 (2014)
  58. 윤혁, "Diagnosis and Management of High Risk Group for Gastric Cancer", Gut and Liver, 9(1), pp.5~17 (2015), 거트앤리버 소화기연관학회협의회
  59. Correa P, "Gastric cancer : overview", Gastroenterol Clin North Am, 42, pp.211~217 (2013)
  60. Rugge M, "Gastric mucosal atrophy : interobserver consistency using new criteria for classification and grading", Aliment Pharmacol Ther, 16, pp.1249~1259 (2002)
  61. Binh TT, "Advanced non-cardia gastric cancer and Helicobacter pylori infection in Vietnam", Gut Pathog, 9, pp.46~ (2017)
  62. Gantuya B, "New observations regarding Helicobacter pylori and gastric cancer in Mongolia", Helicobacter, 23, pp.e12491~ (2018)
  63. Shiota S, "Helicobacter pylori infection in Japan", Expert Rev Gastroenterol Hepatol, 7, pp.35~40 (2013)
  64. Watanabe M, "Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis", Int J Cancer, 131, pp.2632~2642 (2012)
  65. Tan P, "Genetics and molecular pathogenesis of gastric adenocarcinoma", Gastroenterology, 149, pp.1153~1162 (2015)
  66. Correa P, "Does Helicobacter pylori cause gastric cancer via oxidative stress?", Biol Chem, 387, pp.361~364 (2006)
  67. Fischer W, "Strain-specific genes of Helicobacter pylori : genome evolution driven by a novel type IV secretion system and genomic island transfer", Nucleic Acids Res, 38, pp.6089~6101 (2010)
  68. Moodley Y, "Helicobacter pylori research: from bench to bedside", pp.3~27 (2016), Springer Japan
  69. Censini S, "cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and diseaseassociated virulence factors", Proc Natl Acad Sci U S A, 93, pp.14648~14653 (1996)
  70. Backert S, "Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system", Future Microbiol, 10, pp.955~965 (2015)
  71. Olbermann P, "A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island", PLoS Genet, 6, pp.e1001069~ (2010)
  72. Hatakeyama M, "Oncogenic mechanisms of the Helicobacter pylori CagA protein", Nat Rev Cancer, 4, pp.688~694 (2004)
  73. Miftahussurur M, "Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease", Expert Rev Gastroenterol Hepatol, 9, pp.1535~1547 (2015)
  74. Shiota S, "Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in East-Asian countries", Future Microbiol, 5, pp.1885~1893 (2010)
  75. Matsuhisa T, "Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection", World J Gastroenterol, 21, pp.8408~8417 (2015)
  76. Tserentogtokh T, "Westerntype Helicobacter pylori CagA are the most frequent type in Mongolian patients", Cancers(Basel), 11, pp.725~ (2019)
  77. Uchida T, "Analysis of virulence factors of Helicobacter pylori isolated from a Vietnamese population", BMC Microbiol, 9, pp.175~ (2009)
  78. Jung SW, "The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone", Infect Immun, 80, pp.381~387 (2012)
  79. Waskito LA, "Distribution and clinical associations of integrating conjugative elements and cag pathogenicity islands of Helicobacter pylori in Indonesia", Sci Rep, 8, pp.6073~ (2018)
  80. Silva B, "The expression of Helicobacter pylori tfs plasticity zone cluster is regulated by pH and adherence, and its composition is associated with differential gastric IL-8 secretion", Helicobacter, 22, pp.e12390~ (2017)
  81. Delahay RM, "Phylogeographic diversity and mosaicism of the Helicobacter pylori tfs integrative and conjugative elements", Mob DNA, 9, pp.5~ (2018)
  82. Fischer W, "A comprehensive analysis of Helicobacter pylori plasticity zones reveals that they are integrating conjugative elements with intermediate integration specificity", BMC Genomics, 15, pp.310~ (2014)
  83. Kidd M, "Conservation of the cag pathogenicity island is associated with vacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates", Gut, 49, pp.11~17 (2001)
  84. Yamaoka Y, "A M(r)34, 000 proinflammatory outer membrane protein(oipA)of Helicobacter pylori", Proc Natl Acad Sci U S A, 97, pp.7533~7538 (2000)
  85. Yamaoka Y, "Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production", Gastroenterology, 123, pp.414~424 (2002)
  86. Dossumbekova A, "Helicobacter pylori HopH(OipA)and bacterial pathogenicity : genetic and functional genomic analysis of hopH gene polymorphisms", J Infect Dis, 194, pp.1346~1355 (2006)
  87. Yamaoka Y, "Helicobacter pylori in North and South America before Columbus", FEBS Lett, 517, pp.180~184 (2002)
  88. Liu J, "Association of presence", absence and on, BMC Infect Dis, pp.2013, 13[DOI]
  89. Sugano K, "Kyoto global consensus report on Helicobacter pylori gastritis", Gut, 64, pp.1353~1367 (2015)
  90. Mahachai V, "Helicobacter pylori management in ASEAN : the Bangkok consensus report", J Gastroenterol Hepatol, 33, pp.37~56 (2018)
  91. Fock KM, "Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection", J Gastroenterol Hepatol, 24, pp.1587~1600 (2009)
  92. Alba C, "Antibiotic resistance in Helicobacter pylori", Curr Opin Infect Dis, 30, pp.489~497 (2017)
  93. Savoldi A, "Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in world health organization regions", Gastroenterology, 155, pp.1372~1382 (2018)
  94. Vilaichone RK, "Prevalence and pattern of antibiotic resistant strains of Helicobacter pylori infection in ASEAN", Asian Pac J Cancer Prev, 19, pp.1411~1413 (2018)
  95. Miftahussurur M, "Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance : an Asian perspective", Molecules, 20, pp.6068~6092 (2015)
  96. Hu Y, "Helicobacter pylori and antibiotic resistance, a continuing and intractable problem", Helicobacter, 21, pp.349~363 (2016)
  97. Fallone CA, "The Toronto consensus for the treatment of Helicobacter pylori infection in adults", Gastroenterology, 151, pp.51~69 (2016)
  98. Jung YS, "Systematic review with metaanalysis : the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication", Aliment Pharmacol Ther, 46, pp.106~114 (2017)
  99. Malfertheiner P, "Management of Helicobacter pylori infection-the Maastricht V", Florence Consensus Report, 2017, pp.66, 6~30
  100. Davenport ER, "The human microbiome in evolution", BMC Biol, 15, pp.127~ (2017)
  101. Sheh A, "The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis", Gut Microbes, 4, pp.505~531 (2013)
  102. Abreu MT, "Gastrointestinal malignancy and the microbiome", Gastroenterology, 146, pp.1534~1546 (2014)
  103. Bik EM, "Molecular analysis of the bacterial microbiota in the human stomach", Proc Natl Acad Sci U S A, 103, pp.732~737 (2006)
  104. Schütte K, "What is the relevance of gastric microbiota beyond H. pylori?", Curr Treat Options Gastroenterol, 17, pp.619~627 (2019)
  105. Yang I, "Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia", Sci Rep, 6, pp.18594~ (2016)
  106. Schulz C, "The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection", Gut, 67, pp.216~225 (2018)
  107. Ferreira RM, "Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota", Gut, 67, pp.226~236 (2018)
  108. Schulz C, "The role of the gastric bacterial microbiome in gastric cancer : Helicobacter pylori and beyond", Therap Adv Gastroenterol, 12, pp.1756284819894062~ (2019)
  109. Coker OO, "Mucosal microbiome dysbiosis in gastric carcinogenesis", Gut, 67, pp.1024~1032 (2018)
  110. Gao JJ, "Association between gut microbiota and Helicobacter pylori-related gastric lesions in a high-risk population of gastric cancer", Front Cell Infect Microbiol, 8, pp.202~ (2018)
  111. Park CH, "Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing", Helicobacter, 24, pp.e12547~ (2019)

관련 논문AI추천

Characterizing Helicobacter pylori cagA in MyanmarMuhammad Miftahussurur, New Ni, Phawinee Subsomwong, Ratha-korn Vilaichone, Than Than Aye, Thein Myint, Tomohisa Uchida, Varocha Mahachai, Yoshio Yamaoka거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제1호Noninvasive Helicobacter pylori Diagnostic Methods in IndonesiaMuhammad Miftahussurur거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제5호Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer최일주대한내과학회 · The Korean Journal of Internal Medicine2013 · 제28권 제5호Distinct Genetic Variation of Helicobacter pylori cagA, vacA, oipA, and sabA Genes in Thai and Korean Dyspeptic Patients강형련, 백승철, 신민경, 이우곤, 정명환, 조명제, Prasit Palittapongarnpim, Wongwarut Boonyanugomol, Worrarat Kongkasame한국미생물·생명공학회 · 한국미생물·생명공학회지2018 · 제46권 제3호Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from VietnamDang Thuy Ha, Duong Minh Thang, Ho Dang Quy Dung, Nguyen Quang Duat, Pham Hong Khanh, Tran Manh Hai, Tran Thanh Binh, Tran Thi Huyen Trang, Vu Van Khien, Yoshio Yamaoka거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제5호Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical ConsiderationsDavid Y Graham, Hsiu-Hsi Chen, Jyh-Ming Liou, Ming-Shiang Wu, Tsung-Hsien Chiang, Yi-Chia Lee거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제1호

이 간행물의 다른 논문 (17건)